Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Precigen Sponsored Study; Randomized, Open-Label, Two-Arm, Phase 2 Study To Evaluate Efficacy And Safety Of PRGN-2009 In Combination With Pembrolizumab Versus Pembrolizumab In Patients With Recurrent Or Metastatic Cervical Cancer; Update 12/5/2023 "NOT YET RECRUITING"

Author: Benzinga Newsdesk | December 05, 2023 11:33am

Posted In: PGEN